Prior notification of a concentration

(Case M.10875 – AXA IM / SWISS LIFE / MORRISON & CO / LYNTIA NETWORKS)

(Text with EEA relevance)

(2022/C 404/10)

On 7 October 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

—	AXA PIE Lux 4 S.à.r.l. (‘AXA’, France), controlled by AXA S.A.,

—	Swiss Life Investment S.à.r.l. (‘SLAM’, Switzerland), controlled by Swiss Life Holding AG,

—	Sorolla Investment Co S.à.r.l. (‘Sorolla’, New Zealand), controlled by H.R.L. Morrison & Co Group Limited Partnership (‘Morrison’),

—	Gunalta ITG, S.L.U. (‘Lyntia’, Spain), controlled by Antin Infrastructure Partners.

AXA, SLAM and Sorolla will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Lyntia.

The concentration is accomplished by way of purchase of shares.

The business activities of the undertakings concerned are the following:

—	AXA is a global insurance group, active in life, health and other forms of insurance, as well as in investment management, headquartered in France,

—	SLAM is an asset management company that is part of the Swiss Life group, an insurance company listed in Switzerland, and

—	Sorolla is part of Morrison, an investment company investing on behalf of sovereign wealth funds, pension funds and wholesale investors, headquartered in New Zealand.

The business activities of the Target are the following:

—	Lyntia is a neutral optic fibre operator in the telecommunications market, mainly providing services through optic fibre.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10875 – AXA IM / SWISS LIFE / MORRISON & CO / LYNTIA

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).